Best Practices

In the Evolving Mystery of BV, an Innovative Oral Treatment Emerges

This supplement is sponsored by Symbiomix Therapeutics, LLC (a Lupin Company).

 

Click Here to Read the Supplement

Topics include:

  • BV terminology and treatment over time
  • Current understanding of BV etiology
  • BV consequences
  • BV treatments
  • Future research needs in BV

Author:
Steven E. Chavoustie, MD, FACOG, CCRP

University of Miami

Miller School of Medicine

Miami, Florida

Click Here to Read the Supplement

Next Article: